GT Biopharma, Inc. (GTBP)
0.44
+0.01
(+1.62%)
USD |
NASDAQ |
May 22, 16:00
0.4471
+0.01
(+1.61%)
After-Hours: 20:00
GT Biopharma EPS Diluted (Quarterly) : -0.1112 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.833M |
| Total Expenses (Quarterly) | 2.833M |
| Enterprise Value | 6.852M |
| Earnings Yield | -3.27K% |
| Normalized Earnings Yield | -4013.50 |